Oven-baked Home FriesOven-baked White Russet PotatoOven-baked FriesDeep Fried, Quick Serve FriesOven-baked Cauliflower Veggie TotsNo Side
Oven-baked Home Fries: Oven-baked Home Fries (241 g; McCain Ltd.). Test treatments matched for calories (284 kcal)
Oven-baked White Russet Potato: Oven-baked White Russet Potato (299 g). Test treatments matched for calories (284 kcal)
Oven-baked Fries: Oven-baked Fries (201 g; McCain Ltd.). Test treatments matched for calories (284 kcal)
Deep Fried, Quick Serve Fries: Deep Fried, Quick Serve Fries (108 g; McCain Ltd.). Test treatments matched for calories (284 kcal)
Oven-baked Cauliflower Veggie Tots: Oven-baked Cauliflower Veggie Tots (186 g; Green Giant). Test treatments matched for calories (284 kcal)
No Side: No side control (no caloric contribution).
Study summary
The purpose of this study is to evaluate the interaction between white potato consumption and meal timing on glycemic response, subjective appetite, and energy intake in adults. The investigators hypothesize that white potatoes will modulate glycemic response, enhance satiety, and mitigate subsequent meal consumption and overall food intake when compared with meals containing low glycemic carbohydrates. Furthermore, they anticipate that the timing of white potato consumption will yield differential effects, with breakfast consumption exerting a more pronounced impact on satiety and subsequent food intake reduction compared to dinner consumption.
Eligibility
Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria:
* 18 - 65 years
* within the healthy body weight range \[body mass index (BMI) between 18.5 - 24.9 kg/m2\].
Exclusion Criteria:
* have a previous diagnosis of diabetes and gastrointestinal, liver or kidney disease;
* have had a major medical or surgical event within the past 6 months;
* have had any significant weight fluctuation in the past 6-months;
* are taking medication that may influence dependent measures;
* are or have been on a diet within the past 6 months;
* skip breakfast or are unable to consume test treatment food.
Primary outcome measure(s)
Glycemic Response (Acute Phase) — Change from baseline (measured at baseline (0-minute), 15-minute, 30-minute, 60-minute, 90-minute, and 120-minute post-treatment consumption). Blood glucose (mmol/L). Blood glucose concentrations will be measured using a Dexcom G7 CGM system.
Rest-of-day Blood Glucose — Continuous measurements for 24 hours post-treatment consumption. Blood glucose (mmol/L). Rest-of-day blood glucose concentrations will be determined using a Dexcom G7 CGM system.
Ad Libitum Food Intake — At 120 minutes post-treatment consumption Lunch pizza meal. Food intake will be determined by weighing the meal before and after serving. The net weight of the test meal will be converted to calories.
Trial sites (1)
Facility
City
Region
Status
Centre for Urban Innovation (CUI-109), School of Nutrition, Toronto Metropolitan University
Toronto
Ontario
Recruiting
More Toronto Metropolitan University trials in Canada
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.